Phyto Chem (I)

Who are the top shareholders of the Phyto Chem (I)?

The top shareholder of Phyto Chem (I) is promoter Nayudamma Yarlagadda, holding 7.87%. Individual investors own 49.29% of the shares, with no pledged promoter holdings or foreign institutional investors involved.

The top shareholders of Phyto Chem (I) include Nayudamma Yarlagadda, who is the promoter with the highest holding at 7.87%. The majority of the shareholding is held by individual investors, accounting for 49.29% of the shares. There are no pledged promoter holdings, and the company has no foreign institutional investors (FIIs) involved. Additionally, two mutual fund schemes hold a small portion of shares, totaling 0.19%.

What does Phyto Chem (I) do?

Phyto Chem (India) Ltd manufactures and markets pesticides for the agriculture sector. As of March 2025, it reported net sales of 1 Cr and a net loss of 1 Cr, with a market cap of Rs 12 Cr.

Overview: <BR>Phyto Chem (India) Ltd is engaged in the manufacturing and marketing of pesticides for the agriculture sector and operates within the Micro Cap category in the Pesticides & Agrochemicals industry.<BR><BR>History: <BR>Established in January 1989, Phyto Chem (India) Ltd has been involved in the pesticides business since its inception. The latest quarterly results reported are for March 2025, showing net sales and profit figures.<BR><BR>Financial Snapshot: <BR>Net Sales: 1 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: -1 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: Rs 12 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: N/A <BR>Industry P/E: 38 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 2.45 <BR>Return on Equity: -13.59% <BR>Price to Book: 1.65<BR><BR>Contact Details: <BR>Address: Survey No 628 Temple Street, Jinnaram Mandal Bonthapally Medak Telangana : 502313 <BR>Tel: 91-8458-275236 <BR>Email: info@phytochemindia.com <BR>Website: http://www.phytochemindia.com

Who are in the management team of Phyto Chem (I)?

As of March 2022, the management team of Phyto Chem (I) includes Chairman P Sreemannarayana, Managing Director Y Nayudamma, and several directors, including both executive and independent members, totaling twelve key individuals.

As of March 2022, the management team of Phyto Chem (I) includes the following members:<BR><BR>1. P Sreemannarayana - Chairman (Non-Executive)<BR>2. Y Nayudamma - Managing Director<BR>3. Y Venkateswarlu - Director<BR>4. P Anjaneyulu - Director<BR>5. Y Janaki Ramaiah - Executive Director<BR>6. Pavansingh Thakur - Company Secretary & Compliance Officer<BR>7. M Sreerama Murthy - Independent Director<BR>8. G S R Anjaneyulu - Independent Director<BR>9. Yugandhar Sampath Kumar Sakhamuri - Independent Director<BR>10. Vijitha Gorrepati - Independent Director<BR>11. K. Srinivasa Rao - Alternate Director<BR>12. N. Nagendra Naidu - Independent Director<BR><BR>This team comprises a mix of executive, non-executive, and independent directors, contributing to the governance and strategic direction of the company.

Has Phyto Chem (I) declared dividend?

Phyto Chem (India) Ltd has declared a 10% dividend, amounting to ₹1.00 per share, with an ex-date of September 25, 2014. However, the dividend yield is 0%, and total returns over recent periods have been largely negative, except for the 3-year and 4-year spans.

Phyto Chem (India) Ltd has declared a 10% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 10%<BR>- Amount per share: 1.0000<BR>- Ex-date: 25 Sep 14<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was -22.7%, the dividend return was 0%, resulting in a total return of -22.7%.<BR><BR>For the 1-year period, the price return was -8.67%, the dividend return was 0%, leading to a total return of -8.67%.<BR><BR>Over the 2-year period, the price return was -21.4%, with a dividend return of 0%, resulting in a total return of -21.4%.<BR><BR>In the 3-year period, the price return was 29.15%, the dividend return was 0%, which resulted in a total return of 29.15%.<BR><BR>For the 4-year period, the price return was 22.81%, the dividend return was 0%, leading to a total return of 22.81%.<BR><BR>In the 5-year period, the price return was -4.81%, with a dividend return of 0%, resulting in a total return of -4.81%.<BR><BR>Overall, while Phyto Chem (India) Ltd has declared a dividend, the total returns over various periods show significant fluctuations, with negative returns in most periods except for the 3-year and 4-year spans. The dividend yield remains at 0%, indicating that the dividend has not contributed to the overall returns in recent years.

Who are the peers of the Phyto Chem (I)?

Phyto Chem (I) peers include P I Industries, UPL, Bayer CropSci., and others, with varying management and growth risks. Sharda Cropchem leads in 1-year returns at 102.43%, while Phyto Chem (I) has a return of -9.03%.

Peers: The peers of Phyto Chem (I) are P I Industries, UPL, Bayer CropSci., Sumitomo Chemi., Dhanuka Agritech, Sharda Cropchem, Rallis India, Bhagiradha Chem., and Bharat Rasayan.<BR><BR>Quality Snapshot: Excellent management risk is observed at Bayer CropSci., Dhanuka Agritech, and the rest. Good management risk is found at P I Industries, Sumitomo Chemi., Sharda Cropchem, and Bharat Rasayan, while Average management risk is present at UPL, Rallis India, and Bhagiradha Chem. In terms of growth, Excellent growth is seen at P I Industries, while Below Average growth is noted at UPL, Bayer CropSci., Sumitomo Chemi., Dhanuka Agritech, Sharda Cropchem, Rallis India, Bhagiradha Chem., and Bharat Rasayan. Capital Structure is Excellent for P I Industries, Bayer CropSci., Sumitomo Chemi., Dhanuka Agritech, Sharda Cropchem, and Bharat Rasayan, while Good capital structure is found at Bhagiradha Chem., and Below Average at UPL, Rallis India, and Phyto Chem (I).<BR><BR>Return Snapshot: The peer with the highest 1-year return is Sharda Cropchem at 102.43%, while Bharat Rasayan has the lowest at -12.17%. Phyto Chem (I) has a 1-year return of -9.03%, which is higher than Bharat Rasayan's but lower than Sharda Cropchem's. Additionally, UPL, Bharat Rasayan, and Phyto Chem (I) have negative six-month returns.

Is Phyto Chem (I) overvalued or undervalued?

As of May 30, 2024, Phyto Chem (I) is considered risky and overvalued, with poor financial ratios indicating negative earnings performance and significant underperformance compared to industry peers and the Sensex.

As of 30 May 2024, the valuation grade for Phyto Chem (I) has moved from attractive to risky, indicating a significant deterioration in its financial standing. The company is currently assessed as overvalued. Key ratios reveal a PE ratio of -12.21, an EV to EBITDA of -22.40, and a ROE of -13.59%, all of which suggest poor profitability and negative earnings performance.<BR><BR>In comparison to its peers, Phyto Chem (I) stands out unfavorably; for instance, P I Industries has a PE ratio of 35.59, while UPL boasts a PE ratio of 38.74, both indicating a much stronger valuation. The negative ratios and the shift in valuation grade highlight that Phyto Chem (I) is not only underperforming relative to its industry peers but also reflects a concerning trend in its financial health. Additionally, the company's stock has underperformed the Sensex over various time frames, including a year-to-date decline of 17.85% compared to the Sensex's gain of 5.63%.

What is the technical trend for Phyto Chem (I)?

As of May 27, 2025, Phyto Chem (I) has a bearish technical trend, supported by negative MACD indicators and moving averages, while the RSI shows no momentum and Dow Theory indicates no clear trend.

As of 27 May 2025, the technical trend for Phyto Chem (I) has changed from mildly bearish to bearish. The weekly and monthly MACD indicators are both bearish, reinforcing the negative sentiment. The daily moving averages also indicate a bearish stance. Although the Bollinger Bands show a mildly bearish trend on both weekly and monthly time frames, the KST is bearish as well. The RSI shows no signal, indicating a lack of momentum in either direction. Dow Theory confirms no trend on both weekly and monthly levels. Overall, the current technical stance is bearish with a moderate strength, driven primarily by the bearish MACD and moving averages.

How big is Phyto Chem (I)?

As of 24th July, Phyto Chem (India) Ltd has a market capitalization of 13.00 Cr, with recent net sales of 14.09 Cr and a net profit loss of 1.00 Cr over the last four quarters. Shareholder's funds are 7.36 Cr, and total assets are valued at 31.17 Cr.

As of 24th July, <BR><BR>Market Cap: Phyto Chem (India) Ltd has a market capitalization of 13.00 Cr and is classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 14.09 Cr, while the sum of Net Profit for the same period reflects a loss of 1.00 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the latest annual data is March 2024. Shareholder's Funds stand at 7.36 Cr, and Total Assets are valued at 31.17 Cr.

When is the next results date for Phyto Chem (I)?

Phyto Chem (I) will announce its results on 14 November 2025.

Phyto Chem (I) will declare its results on 14 November 2025.

How has been the historical performance of Phyto Chem (I)?

Phyto Chem (I) has shown a declining trend in net sales and profitability, with net sales dropping from 44.49 Cr in Mar'21 to 14.08 Cr in Mar'25, resulting in significant losses and negative operating profit. The company's financial health has deteriorated, reflected in increasing losses and stagnant cash flow.

Answer:<BR>The historical performance of Phyto Chem (I) shows a declining trend in net sales and profitability over the years, with significant losses reported in the most recent fiscal year.<BR><BR>Breakdown:<BR>Phyto Chem (I) has experienced a consistent decline in net sales, dropping from 44.49 Cr in Mar'21 to just 14.08 Cr in Mar'25. This decline is mirrored in total operating income, which also fell from 44.49 Cr in Mar'21 to 14.08 Cr in Mar'25. The company's total expenditure has decreased from 42.28 Cr in Mar'21 to 15.42 Cr in Mar'25, yet it remains higher than the operating income, resulting in an operating profit (PBDIT) that has turned negative, reaching -1.34 Cr in Mar'25. Profit before tax has similarly worsened, moving from a profit of 0.47 Cr in Mar'21 to a loss of 1.05 Cr in Mar'25, leading to a profit after tax of -0.99 Cr for the same period. The earnings per share have also deteriorated, showing a loss of -2.3 in Mar'25 compared to a profit of 1.14 in Mar'21. On the balance sheet, total liabilities have decreased from 67.59 Cr in Mar'20 to 27.30 Cr in Mar'25, while total assets have similarly declined from 67.59 Cr to 27.30 Cr over the same period. The company has reported no cash inflow or outflow in recent years, indicating a stagnant cash position. Overall, Phyto Chem (I) has faced significant challenges, reflected in its declining sales, increasing losses, and deteriorating financial health.

Are Phyto Chem (India) Ltd latest results good or bad?

Phyto Chem (India) Ltd's latest results are concerning, showing a net loss of ₹0.56 crore for Q2 FY26 and negative operating margins, despite a 190.67% sequential increase in net sales. Overall, the company faces significant operational and financial challenges, indicating a negative outlook.

Phyto Chem (India) Ltd's latest results indicate a challenging financial situation. In Q2 FY26, the company reported a net loss of ₹0.56 crore, marking its third consecutive loss-making quarter. While net sales of ₹4.36 crore showed a significant sequential recovery of 190.67% from the previous quarter, they declined by 0.23% year-on-year. <BR><BR>The operating margin was deeply negative at -10.09%, reflecting ongoing operational inefficiencies, and the return on equity (ROE) stood at -10.64%, indicating a destruction of shareholder value. The company's financial performance has been characterized by persistent negative operating margins and a significant decline in sales over the past year, with a half-yearly sales drop of 34.74%.<BR><BR>Overall, these results suggest that Phyto Chem is facing severe operational and financial challenges, leading to a negative outlook for the company. The combination of ongoing losses, negative profitability metrics, and high financial leverage paints a concerning picture for its future viability.

Should I buy, sell or hold Phyto Chem (India) Ltd?

Why is Phyto Chem (India) Ltd falling/rising?

As of 16-Mar, Phyto Chem (India) Ltd's stock price has risen to 26.19, reflecting a 0.77% increase, driven by short-term gains and sector outperformance. However, the company's long-term fundamentals are weak, with operating losses and declining investor confidence.

As of 16-Mar, Phyto Chem (India) Ltd is experiencing a rise in its stock price, currently at 26.19, with a change of 0.2 (0.77%) upward. This increase can be attributed to several factors. Notably, the stock has outperformed its sector by 1.02% today and has shown a consecutive gain over the last two days, resulting in an impressive 11.02% return during this period. Additionally, the stock's performance over the past week has been strong, with a 9.54% increase, contrasting sharply with the Sensex, which has declined by 2.66% in the same timeframe.<BR><BR>However, it is important to note that despite this recent uptick, the company faces significant challenges. The long-term fundamentals are weak, characterized by operating losses and a negative growth trajectory in net sales and operating profit over the past five years. The company has also seen a decrease in institutional investor participation, which fell by 4.62% in the previous quarter, indicating a lack of confidence among more knowledgeable investors.<BR><BR>In summary, while Phyto Chem (India) Ltd is currently rising in stock price due to short-term performance and sector outperformance, the underlying financial health and long-term prospects remain concerning, as evidenced by its historical performance and fundamental weaknesses.

Which are the latest news on Phyto Chem (I)?